WHO approves AstraZeneca-Oxford's COVID-19 vaccines for emergency use
https://ift.tt/2OKZYiN
The World Health Organisation (WHO) on Monday (local time) gave emergency use approval (EUA) to two versions of AstraZeneca-Oxford-developed COVID-19 vaccines, allowing these shots to be rolled out globally through COVAX. The vaccines are being produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India. WHO's EUL assesses the quality, safety and efficacy of COVID-19 vaccines. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.
The World Health Organisation (WHO) on Monday (local time) gave emergency use approval (EUA) to two versions of AstraZeneca-Oxford-developed COVID-19 vaccines, allowing these shots to be rolled out globally through COVAX. The vaccines are being produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India. WHO's EUL assesses the quality, safety and efficacy of COVID-19 vaccines. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.
No comments